Maintenance window scheduled to begin at February 14th 2200 est. until 0400 est. February 15th

(e.g. yourname@email.com)

Forgot Password?

    Defense Visual Information Distribution Service Logo

    USAMMDA team joins DoD, medical development industry leaders for annual health symposium in Kissimmee, Florida

    USAMMDA team joins DoD, medical development industry leaders for annual health symposium in Kissimmee, Florida

    Photo By T. T. Parish | Team members with the U.S. Army Medical Materiel Development Activity set up booth...... read more read more

    KISSIMMEE, FLORIDA, UNITED STATES

    08.26.2024

    Story by T. T. Parish and Cameron Parks

    U.S. Army Medical Materiel Development Activity (USAMMDA)

    Team members with the U.S. Army Medical Materiel Development Activity joined several hundred military and medical development industry experts today to kick off the Department of Defense’s annual four-day Military Health System Research Symposium in Kissimmee, Florida, Aug. 26, 2024.

    MHSRS is an annual DoD-sponsored gathering to bring together leading experts from across the military and private sector medical development industry to discuss the current and future states of military medicine, and to showcase the latest in developing technologies, treatments, and devices designed to preserve and protect the lives of America’s Warfighters.

    During MHSRS, USAMMDA development experts plan to showcase the top-tier medical technology, devices, and treatments currently under development through partnerships and agreements with both DoD and private sector organizations. USAMMDA currently has more than two dozen ongoing research and development programs across the spectrum of combat casualty care. The team will highlight these efforts with a comprehensive display of treatments, devices, and capabilities, from point of injury and evacuation to hospitalization care.

    USAMMDA’s participation in MHSRS requires months of planning and coordination with key stakeholders across USAMMDA for a chance to build relationships with potential future partners. The week is designed to shine a spotlight on the vital work of advanced developer in military medicine and build awareness of DoD programs and projects designed to meet the needs of medical providers in the Army and its sister services.

    This year is especially noteworthy due to the evolving structure of USAMMDA and the transformation of efforts within U.S. military medicine. Three of USAMMDA’s Project Management Offices – Warfighter Readiness, Performance, and Brain Health; Warfighter Expeditionary Medicine and Treatment; and Warfighter Protection and Acute Care – are continuing their organizational transition to the Defense Health Agency. USAMMDA’s Soldier Medical Devices PMO is transitioning to the Program Executive Office-Soldier.

    MHSRS is an opportunity to show USAMMDA’s current and potential partners the strength of its core programs, its persistent focus on meeting the needs of U.S. Joint-Force medical providers, and continued innovation and partnership with key stakeholders from the DoD and partner organizations, said Col. Andy Nuce, USAMMDA’s commander.

    “MHSRS is a premier event for USAMMDA, and I am excited to lead this dynamic and innovative team to show the enterprise what we do each day to meet the needs of America’s Warfighters,” said Nuce, who has guided USAMMDA during a series of structural and administrative changes since June 2022. “Organizational changes are always challenging, and there are a lot of complex issues we have worked over the past few years, but we have exceeded all expectations throughout the process.

    The credit for our success, as always, goes to the staff who have planned diligently, remained flexible, and kept a crystal-clear focus on organizational readiness and exceptionalism to continue serving our end-users across the DoD. I could not be any prouder of every person on the team, and this week at MHSRS is a one-of-a-kind way to show the results of our work.”

    USAMMDA develops, delivers, and fields critical drugs, vaccines, biologics, devices, and medical support equipment to protect and preserve the lives of Warfighters across the globe. USAMMDA Project Managers guide the development of medical products for the U.S. Army Medical Department, other U.S. military services, the Joint Staff, the Defense Health Agency, and the U.S. Special Operations community.

    The process takes promising technology from the Department of Defense, industry, and academia to U.S. Forces, from the testing required for U.S. Food and Drug Administration approval or licensing to fielding and sustainment of the finished product. USAMMDA Project Management Offices will transition to a Program Executive Office under the Defense Health Agency, Deputy Assistant Director for Acquisition and Sustainment.

    Media representatives may request more information by emailing the USAMMDA Public Affairs Office at usarmy.detrick.medcom-usammda.mbx.usammda-pao@health.mil.

    For more information about USAMMDA and how to partner with the U.S. Army and DoD medical development enterprises, visit https://usammda.health.mil/.

    NEWS INFO

    Date Taken: 08.26.2024
    Date Posted: 08.26.2024 15:31
    Story ID: 479387
    Location: KISSIMMEE, FLORIDA, US

    Web Views: 41
    Downloads: 0

    PUBLIC DOMAIN